citrulline has been researched along with glucagon-like peptide 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Assi, SG; Bernstein, CN; Buchman, AL; Fang, JC; Katz, S | 1 |
| Bouvy, N; Buurman, WA; Greve, JW; Rensen, SS; Roosta, S; van Eijk, H; Verdam, FJ | 1 |
| Acosta, A; Burton, D; Camilleri, M; Carlson, PJ; Edakkanambeth Varayil, J; Hurt, R; Iturrino, J; O'Neill, J; Zinsmeister, AR | 1 |
| Mutanen, A; Pakarinen, MP | 1 |
| Cinkajzlová, A; Haluzík, M; Kaválková, P; Kloučková, J; Kratochvílová, H; Křížová, J; Lacinová, Z; Mráz, M; Trachta, P | 1 |
| Achiam, MP; Ambrus, R; Hvistendahl, MK; Jeppesen, PB; Kissow, H; Naimi, RM; Nerup, NA; Pedersen, J; Poulsen, SS; Svendsen, LB | 1 |
| Bergmann, KR; Bolognani, F; Crenn, P; de Kam, ML; Gal, P; Greig, G; Kruithof, AC; Machacek, M; Moerland, M; Schulthess, P; van Gent, M | 1 |
4 trial(s) available for citrulline and glucagon-like peptide 2
| Article | Year |
|---|---|
Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.
Topics: Adolescent; Adult; Citrulline; Crohn Disease; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Glucagon-Like Peptide 2; Humans; Male; Middle Aged; Peptides; Treatment Outcome; Young Adult | 2010 |
Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
Topics: Adult; Aged; Citrulline; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Tract; Glucagon-Like Peptide 2; Humans; Intestinal Absorption; Lactulose; Male; Mannitol; Middle Aged; Parenteral Nutrition, Home; Peptides; Permeability; Pilot Projects; Recombinant Proteins; Short Bowel Syndrome; Treatment Outcome | 2016 |
Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial.
Topics: Citrulline; Glucagon-Like Peptide 2; Humans; Intestines; Perfusion; Short Bowel Syndrome | 2023 |
Characterization of the Pharmacokinetic and Pharmacodynamic Profile of Apraglutide, a Glucagon-Like Peptide-2 Analog, in Healthy Volunteers.
Topics: Adult; Citrulline; Glucagon-Like Peptide 2; Healthy Volunteers; Humans; Peptides | 2023 |
3 other study(ies) available for citrulline and glucagon-like peptide 2
| Article | Year |
|---|---|
Small intestinal alterations in severely obese hyperglycemic subjects.
Topics: Adult; Biopsy; Cell Proliferation; Chronic Disease; Citrulline; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Enterocytes; Fatty Acid-Binding Proteins; Female; Glucagon-Like Peptide 2; Glycated Hemoglobin; Humans; Hyperglycemia; Intestine, Small; Male; Obesity; Organ Size; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure.
Topics: Adaptation, Physiological; Adolescent; Body Mass Index; Case-Control Studies; Child; Child, Preschool; Citrulline; Cross-Sectional Studies; Fasting; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Infant; Intestinal Diseases; Intestines; Male; Parenteral Nutrition | 2017 |
Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition.
Topics: Acute-Phase Proteins; Aged; Biomarkers; Carrier Proteins; Case-Control Studies; Citrulline; Fatty Acid-Binding Proteins; Female; Glucagon-Like Peptide 2; Haptoglobins; Humans; Intestinal Absorption; Intestine, Small; Male; Membrane Glycoproteins; Middle Aged; Parenteral Nutrition; Permeability; Protein Precursors; Short Bowel Syndrome; Treatment Outcome | 2019 |